Table I.
Comparison of baseline data between two groups.
| Item | Control group, n=91 | Observation group, n=55 | t/χ2 | P-value |
|---|---|---|---|---|
| Male/female | 52/39 | 33/22 | 0.115 | 0.734 |
| Age, year | 58.8±7.6 | 59.6±7.5 | 0.230 | 0.685 |
| Time of onset, h | 8.2±2.5 | 8.3±2.4 | 0.167 | 0.722 |
| Smoke, cases (%) | 13 (14.29) | 8 (14.55) | 0.002 | 0.965 |
| Diabetes, cases (%) | 10 (10.99) | 6 (10.91) | 0.000 | 0.988 |
| Cholesterol total, mmol/l | 5.7±0.8 | 5.8±0.7 | 0.245 | 0.623 |
| Low density lipoprotein, mmol/l | 4.5±1.0 | 4.7±1.2 | 0.324 | 0.522 |
| BMI, kg/m2 | 22.4±2.2 | 22.6±2.5 | 0.335 | 0.503 |
| mSBP, mmHg | 165.7±4.3 | 167.2±4.4 | 0.267 | 0.642 |
| mDBP, mmHg | 102.4±5.2 | 103.6±5.6 | 0.423 | 0.527 |
| Cerebral vascular stenosis rate, % | 96.8±3.3 | 97.2±3.5 | 0.236 | 0.647 |
| Stent length, mm | 12.3±3.2 | 13.4±3.3 | 0.326 | 0.632 |
BMI, body mass index; mSBP, mean systolic blood pressure; mDBP, mean diastolic blood pressure.